AXSM vs. AGX
AXSM (Axsome Therapeutics, Inc.) and AGX (Argan, Inc.) are both stocks. AXSM operates in Biotechnology (Healthcare), while AGX operates in Engineering & Construction (Industrials). Over the past 10 years, AXSM returned 39.88%/yr vs 34.05%/yr for AGX. At a 0.17 correlation, their price movements are largely independent.
Performance
AXSM vs. AGX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AXSM achieves a 28.75% return, which is significantly lower than AGX's 98.28% return. Over the past 10 years, AXSM has outperformed AGX with an annualized return of 39.88%, while AGX has yielded a comparatively lower 34.05% annualized return.
AXSM
- 1D
- 1.21%
- 1M
- 8.17%
- YTD
- 28.75%
- 6M
- 59.35%
- 1Y
- 110.12%
- 3Y*
- 47.19%
- 5Y*
- 29.93%
- 10Y*
- 39.88%
AGX
- 1D
- -10.76%
- 1M
- -8.86%
- YTD
- 98.28%
- 6M
- 94.57%
- 1Y
- 156.50%
- 3Y*
- 156.79%
- 5Y*
- 69.15%
- 10Y*
- 34.05%
AXSM vs. AGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 28.75% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
AGX Argan, Inc. | 98.28% | 130.61% | 198.31% | 30.24% | -2.01% | -11.64% | 19.15% | 8.62% | -14.32% | -34.26% |
Correlation
The correlation between AXSM and AGX is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2015 | 0.17 |
Fundamentals
AXSM:
$12.04B
AGX:
$8.80B
AXSM:
-$3.74
AGX:
$11.38
AXSM:
16.71
AGX:
8.43
AXSM:
220.54
AGX:
18.59
AXSM:
$708.24M
AGX:
$1.04B
AXSM:
$655.82M
AGX:
$217.93M
AXSM:
-$172.72M
AGX:
$163.99M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXSM vs. AGX — Risk / Return Rank
AXSM
AGX
AXSM vs. AGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Argan, Inc. (AGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AXSM | AGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.55 | ||
| Sortino ratioReturn per unit of downside risk | +1.16 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.36 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 5.99 | 6.31 | -0.32 |
| Martin ratioReturn relative to average drawdown | 17.16 | 18.30 | -1.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AXSM | AGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.65 | 2.10 | +0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.43 | 1.37 | -0.94 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.75 | -0.30 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.05 | +0.34 |
Drawdowns
AXSM vs. AGX - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum AGX drawdown of -94.37%. Use the drawdown chart below to compare losses from any high point for AXSM and AGX.
Loading charts...
Drawdown Indicators
| AXSM | AGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.65% | -94.37% | +7.72% |
Max Drawdown (1Y)Largest decline over 1 year | -18.50% | -24.96% | +6.46% |
Max Drawdown (3Y)Largest decline over 3 years | -36.45% | -43.75% | +7.30% |
Max Drawdown (5Y)Largest decline over 5 years | -72.91% | -43.75% | -29.16% |
Max Drawdown (10Y)Largest decline over 10 years | -81.26% | -54.61% | -26.65% |
Current DrawdownCurrent decline from peak | -0.35% | -16.32% | +15.97% |
Average DrawdownAverage peak-to-trough decline | -39.55% | -48.35% | +8.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.56% | 9.50% | -2.94% |
Volatility
AXSM vs. AGX - Volatility Comparison
The current volatility for Axsome Therapeutics, Inc. (AXSM) is 9.83%, while Argan, Inc. (AGX) has a volatility of 17.80%. This indicates that AXSM experiences smaller price fluctuations and is considered to be less risky than AGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AXSM | AGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.83% | 17.80% | -7.97% |
Volatility (6M)Calculated over the trailing 6-month period | 32.98% | 55.76% | -22.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.79% | 75.04% | -33.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.31% | 50.86% | +19.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.68% | 45.84% | +44.84% |
Dividends
AXSM vs. AGX - Dividend Comparison
AXSM has not paid dividends to shareholders, while AGX's dividend yield for the trailing twelve months is around 0.30%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGX Argan, Inc. | 0.30% | 0.52% | 0.93% | 2.24% | 2.71% | 1.94% | 7.31% | 2.49% | 1.98% | 4.44% | 1.42% | 2.16% |
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
AXSM vs. AGX - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Argan, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. AGX - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
AGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a gross profit of 61.11M and revenue of 290.95M. Therefore, the gross margin over that period was 21.0%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
AGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported an operating income of 45.40M and revenue of 290.95M, resulting in an operating margin of 15.6%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
AGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Argan, Inc. reported a net income of 46.06M and revenue of 290.95M, resulting in a net margin of 15.8%.
Frequently Asked Questions
AXSM and AGX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AGX has higher volatility (17.80%) compared to AXSM (9.83%). In terms of maximum drawdown, AXSM dropped -86.65% vs AGX's -94.37%.
AXSM currently has the higher Sharpe Ratio (2.65 vs 2.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AXSM and AGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer